Double CRM diseases

1 paper1 finding

Humans1

Associations

1

PhenoAge

upin humans1HR 1.26

1 study

PhenoAge predicts double CRM diseases in humans (HR 1.26, 95% CI 1.22-1.31).
“1.26 (95% CI 1.22-1.31), and 1.24 (95% CI 1.12-1.37) for the transitions to first, double, and triple CRM disease, respectively”
Humansn = 330,177
Proteomics mediates the effects of biological aging on the progression of cardio-renal-metabolic comorbidity: a UK biobank cohort study
Cardiovascular diabetology9 Dec 2025

More on PhenoAge

Latest

1 in 12 months

Cardiovascular Diabetology10 Dec

Proteomics mediates the effects of biological aging on the progression of cardio-renal-metabolic comorbidity: a UK biobank cohort study

Cohort study of 330,177 peopleBiomarkers